{
    "clinical_study": {
        "@rank": "147993", 
        "arm_group": [
            {
                "arm_group_label": "Acupuncture & Nerve block", 
                "arm_group_type": "Experimental", 
                "description": "Acupuncture will be performed 3 times per week, total 9 sessions, during 3 weeks. Epidural nerve block and medial branch block will be performed once per week, total 3 sessions, during 3 weeks."
            }, 
            {
                "arm_group_label": "Nerve block", 
                "arm_group_type": "Active Comparator", 
                "description": "Epidural nerve block and medial branch block will be performed once per week, total 3 sessions, during 3 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to investigate the effectiveness of acupuncture for alleviating pain from\n      Spinal Compression Fracture in Patients Treated with Nerve Block."
        }, 
        "brief_title": "Efficacy Study of Acupuncture on Spinal Compression Fracture", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Spinal Compression Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Fractures, Compression"
            ]
        }, 
        "detailed_description": {
            "textblock": "Spinal compression fracture is mainly caused by trauma, furthermore, in old age,\n      osteoporosis increases the risk of spinal compression fracture. Nerve block is effective for\n      the management of pain from inflammation or nerve root stimulation from spinal compression\n      fracture. As one of alternative interventions, acupuncture is effective for controlling\n      spinal compression fracture.\n\n      This study aims to investigate that combination with acupuncture and nerve block may relieve\n      spinal compression fracture-related pain versus nerve block alone."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Vertebral compression fracture by trauma or osteoporosis\n\n          -  Minimum 15% height loss of vertebrae\n\n          -  Patient diagnosed with x-ray or computed tomography (CT) or magnetic resonance image\n             (MRI)\n\n          -  Visual analogue scale (VAS) score of 5 or more\n\n          -  Age over 50\n\n          -  2 weeks from onset or more\n\n          -  Follow-up possible during the clinical trial\n\n          -  Written informed consent voluntarily\n\n        Exclusion Criteria:\n\n          -  Within 2 weeks from onset\n\n          -  Pathological fracture due to malignancy/myeloma, osteomyelitis\n\n          -  Major retropulsion of bony segments into the spinal canal\n\n          -  Bone metabolic disease\n\n          -  Significant renal or hepatic disease\n\n          -  Hypersensitive reaction to acupuncture treatment\n\n          -  Senile dementia, impaired cognitive function or other cerebral disease, severe\n             psychiatric or psychological disorders\n\n          -  Alcohol/drug abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913587", 
            "org_study_id": "CIMI-13-01-21"
        }, 
        "intervention": [
            {
                "arm_group_label": "Acupuncture & Nerve block", 
                "description": "Acupuncture points are ST36, GB34 (bilateral), BL60 (bilateral), BL40 (bilateral), and 2 Back-su points (bilateral). Back-su points are selected as close as possible to pain region. Electroacupuncture will be performed at only 2 Back-su points (bilateral).", 
                "intervention_name": "Acupuncture", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Acupuncture & Nerve block", 
                    "Nerve block"
                ], 
                "description": "Epidural nerve block uses the mixture (10ml) of dexamethasone (10 mg) and bupivacaine (10 mg) dissolved in saline solution. Medial branch block uses mepivacaine (10 mg).", 
                "intervention_name": "Nerve block", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Daegu", 
                    "country": "Korea, Republic of", 
                    "state": "Kyungsangbukdo"
                }, 
                "name": "Daegu Catholic University Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety of Acupuncture on Spinal Compression Fracture in Patients Treated With Nerve Block", 
        "overall_contact": {
            "email": "jychung@cu.ac.kr", 
            "last_name": "Jin-Young Chung, M.D,Ph.D", 
            "phone": "+82 53 650 4505"
        }, 
        "overall_official": [
            {
                "affiliation": "Comprehensive and Intergrative Medicine Institute", 
                "last_name": "Jeong-Chul Seo, KMD, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Daegu Oriental Hospital of Daegu Haany University", 
                "last_name": "Min-Ah Gwak, KMD, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Comprehensive and Integrative Medicine Insitute", 
                "last_name": "Seong-Hoon Park, KMD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The patients will be required to document 100mm pain VAS, where '0' represents 'no pain' and '100', 'unbearable pain'. The change of pain will be reported by comparing the mean VAS before treatment, after 3 week, and 5 week (2 weeks follow-up).", 
            "measure": "Visual analogue scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to 5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913587"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Daegu Catholic University Medical Center", 
            "investigator_full_name": "Jin-Young, Chung", 
            "investigator_title": "Department of anesthesiolgy", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluation will performed before treatment, after 3 week, and 5 week (2 weeks follow-up).", 
                "measure": "Short form McGill pain questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 5 weeks"
            }, 
            {
                "description": "Evaluation will be performed before treatment, after 3 week, and 5 week (2 weeks follow-up).", 
                "measure": "Oswestry Disability Index (ODI)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 5 weeks"
            }
        ], 
        "source": "Daegu Catholic University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Daegu Catholic University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}